Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA

Mallik Greene,1 Luciano Paladini,2 Teresa Lemmer,2 Alexandra Piedade,2 Maelys Touya,3 Otavio Clark2 1Health Economics & Outcomes Research, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA; 2Evidências – Kantar Health, Campinas, Braz...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Greene M, Paladini L, Lemmer T, Piedade A, Touya M, Clark O
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Bipolar disorder pharmacological treatment adherence drug therapy USA Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/84ccf357ef004e9f85c09940de7e8b04
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:84ccf357ef004e9f85c09940de7e8b04
record_format	dspace
spelling	oai:doaj.org-article:84ccf357ef004e9f85c09940de7e8b042021-12-02T01:56:22ZSystematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA1178-2021https://doaj.org/article/84ccf357ef004e9f85c09940de7e8b042018-06-01T00:00:00Zhttps://www.dovepress.com/systematic-literature-review-on-patterns-of-pharmacological-treatment--peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Mallik Greene,1 Luciano Paladini,2 Teresa Lemmer,2 Alexandra Piedade,2 Maelys Touya,3 Otavio Clark2 1Health Economics & Outcomes Research, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA; 2Evidências – Kantar Health, Campinas, Brazil; 3Lundbeck Pharmaceuticals Services, LLC, Deerfield, IL, USA Background: Bipolar disorder type I (BD-I) is a chronic condition characterized by mania episodes followed by syndromic recovery periods, usually permeated by depressive symptomatology and recurring acute manic episodes. It requires long-term pharmacological treatment; thus, it is critical to understand the patterns of drug therapy use and medication compliance to better plan health care policies and needs. This systematic literature review aims to study these data among patients with BD-I in the USA, focusing on medications to treat mania. Methods: Articles published in the last 10 years to October 2016 were searched on MEDLINE and Embase. Studies on patterns of drug therapy, concordance of prescription with clinical practice guidelines, and adherence and persistence with pharmacological treatments for BD-I in the USA under observational conditions, with focus on treatments for mania, were selected. Results: Treatment prevalence for BD-I is low in the USA, with the most current study showing a 46% 12-month rate. There is a lack of studies addressing the use of long-acting injectable (LAI) antipsychotics. Second-generation antipsychotics (SGAs) have been used by nearly all patients receiving oral antipsychotics since the 2000s. However, 30%–60% of individuals with BD do not receive appropriate treatment, and adherence to oral therapies is poor, with medication possession ratios ≥80% seen in only approximately 60% of patients. For persistence rates, results suggest that treatment duration is short for a condition with recommendation for at least 6 months of maintenance therapy. Literature indicates that LAI SGAs may be related to better adherence and persistence. Conclusion: There is a need for studies addressing specifically patterns of therapy and adherence to pharmacological treatment in BD-I patients in the USA to better understand the value of current standards, and an urgent need to improve the rates of adherence and persistence to BD-I pharmacotherapy and to increase the understanding of LAI SGAs’ potential to address this issue. Keywords: polypharmacy, clinical practice guidelines, oral treatment, bipolar mania, treatment patterns, persistenceGreene MPaladini LLemmer TPiedade ATouya MClark ODove Medical PressarticleBipolar disorderpharmacological treatmentadherencedrug therapyUSANeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 1545-1559 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Bipolar disorder pharmacological treatment adherence drug therapy USA Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Bipolar disorder pharmacological treatment adherence drug therapy USA Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Greene M Paladini L Lemmer T Piedade A Touya M Clark O Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
description	Mallik Greene,1 Luciano Paladini,2 Teresa Lemmer,2 Alexandra Piedade,2 Maelys Touya,3 Otavio Clark2 1Health Economics & Outcomes Research, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA; 2Evidências – Kantar Health, Campinas, Brazil; 3Lundbeck Pharmaceuticals Services, LLC, Deerfield, IL, USA Background: Bipolar disorder type I (BD-I) is a chronic condition characterized by mania episodes followed by syndromic recovery periods, usually permeated by depressive symptomatology and recurring acute manic episodes. It requires long-term pharmacological treatment; thus, it is critical to understand the patterns of drug therapy use and medication compliance to better plan health care policies and needs. This systematic literature review aims to study these data among patients with BD-I in the USA, focusing on medications to treat mania. Methods: Articles published in the last 10 years to October 2016 were searched on MEDLINE and Embase. Studies on patterns of drug therapy, concordance of prescription with clinical practice guidelines, and adherence and persistence with pharmacological treatments for BD-I in the USA under observational conditions, with focus on treatments for mania, were selected. Results: Treatment prevalence for BD-I is low in the USA, with the most current study showing a 46% 12-month rate. There is a lack of studies addressing the use of long-acting injectable (LAI) antipsychotics. Second-generation antipsychotics (SGAs) have been used by nearly all patients receiving oral antipsychotics since the 2000s. However, 30%–60% of individuals with BD do not receive appropriate treatment, and adherence to oral therapies is poor, with medication possession ratios ≥80% seen in only approximately 60% of patients. For persistence rates, results suggest that treatment duration is short for a condition with recommendation for at least 6 months of maintenance therapy. Literature indicates that LAI SGAs may be related to better adherence and persistence. Conclusion: There is a need for studies addressing specifically patterns of therapy and adherence to pharmacological treatment in BD-I patients in the USA to better understand the value of current standards, and an urgent need to improve the rates of adherence and persistence to BD-I pharmacotherapy and to increase the understanding of LAI SGAs’ potential to address this issue. Keywords: polypharmacy, clinical practice guidelines, oral treatment, bipolar mania, treatment patterns, persistence
format	article
author	Greene M Paladini L Lemmer T Piedade A Touya M Clark O
author_facet	Greene M Paladini L Lemmer T Piedade A Touya M Clark O
author_sort	Greene M
title	Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
title_short	Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
title_full	Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
title_fullStr	Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
title_full_unstemmed	Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
title_sort	systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type i in the usa
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/84ccf357ef004e9f85c09940de7e8b04
work_keys_str_mv	AT greenem systematicliteraturereviewonpatternsofpharmacologicaltreatmentandadherenceamongpatientswithbipolardisordertypeiintheusa AT paladinil systematicliteraturereviewonpatternsofpharmacologicaltreatmentandadherenceamongpatientswithbipolardisordertypeiintheusa AT lemmert systematicliteraturereviewonpatternsofpharmacologicaltreatmentandadherenceamongpatientswithbipolardisordertypeiintheusa AT piedadea systematicliteraturereviewonpatternsofpharmacologicaltreatmentandadherenceamongpatientswithbipolardisordertypeiintheusa AT touyam systematicliteraturereviewonpatternsofpharmacologicaltreatmentandadherenceamongpatientswithbipolardisordertypeiintheusa AT clarko systematicliteraturereviewonpatternsofpharmacologicaltreatmentandadherenceamongpatientswithbipolardisordertypeiintheusa
_version_	1718402788231217152

Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA

Ejemplares similares